keyword pages:  <<  <  350  351  352  353  354  355  >  >>
< 3172 of 10000 >
Actor demo reel DVD cover art (to watch the full actor demo reel, go to http://www.youtube.com/watch?v=oQwX0KkHxew )
Liz Stephen with Kikkan Randall 2012 FIS Cross Country World Cup finals in Falun, Sweden Photo © Matt Whitcomb/U.S. Ski Team
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the General Session 3 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the General Session 3 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the Press Conference at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Loibl discusses S3-1. Neoadjuvant chemotherapy in the very young 35 years of age or younger during the Press Conference at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the Press Conference at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the Press Conference at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the Press Conference at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the General Session 3 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the General Session 3 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: S Aebi discusses S3-2. Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) during the General Session 3 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
See photo in original gallery.
keyword pages:  <<  <  350  351  352  353  354  355  >  >>
< 3172 of 10000 >